Literature DB >> 793890

Pathology of influenza hepatitis in susceptible and genetically resistant mice.

H Arnheiter, O Haller, J Lindenmann.   

Abstract

Mice resistant (homozygous or heterozygous for the gene Mx) and mice susceptible to the lethal effect of influenza viruses were inoculated intraperitoneally and intraportally with a hepatotropic variant of influenza A virus. Disease evolution was followed histologically and by immunofluorescence. In susceptible animals, rapidly spreading foci of hepatocyte necrosis with little inflammatory infiltration was observed. Death occurred on the 3rd day, when the entire liver was involved. In resistant animals foci became detectable later, and were fewer and smaller. They were infiltrated by cells morphologically resembling liver macrophages (Kupffer cells), and they regressed from the 4th day after infection. Barriers to virus spread appeared to be present at all stages of the disease.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 793890     DOI: 10.1159/000163103

Source DB:  PubMed          Journal:  Exp Cell Biol        ISSN: 0304-3568


  4 in total

1.  Primary monolayer culture of adult mouse hepatocytes -- a model for the study of hepatotropic viruses.

Authors:  H Arnheiter
Journal:  Arch Virol       Date:  1980       Impact factor: 2.574

Review 2.  The role of host genetics in susceptibility to influenza: a systematic review.

Authors:  Peter Horby; Nhu Y Nguyen; Sarah J Dunstan; J Kenneth Baillie
Journal:  PLoS One       Date:  2012-03-15       Impact factor: 3.240

3.  Natural, genetically determined resistance toward influenza virus in hemopoietic mouse chimeras. Role of mononuclear phagocytes.

Authors:  O Haller; H Arnheiter; J Lindenmann
Journal:  J Exp Med       Date:  1979-07-01       Impact factor: 14.307

4.  Development of an improved anesthesia protocol to increase CF1 mice survival in a portal vein infection with Echinococcus granulosus sensu lato protoscoleces.

Authors:  Nathalia P Scioscia; Patricia E Pensel; Guillermo M Denegri; María Celina Elissondo
Journal:  Heliyon       Date:  2021-03-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.